Externalized Immune System (EXIS™) Platform Applications
Prellis’ proprietary, industry-leading two-photon 3D printing technology supports large, complex tumor co-culture systems mimicking tumor microenvironments, enabling the interrogation of interactive biological systems for uniquely relevant prioritization of immuno-oncology therapeutics.
Harnessing the power of the human immune system to build next generation medicines.
Prellis Biologics Announces Collaboration with Sanofi.
3D printed lymph nodes advance drug discovery and development
Prellis’ Externalized Immune System (EXIS™) platform recreates human immunobiology in vitro in the form of lymph node organoids (LNOs™). 3D printed LNOs™ allow direct access to a fully functional human immune system for antibody discovery, immunogenicity evaluation, and vaccine development.